Financhill
Back

Indaptus Therapeutics, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25

INDP
Indaptus Therapeutics, Inc.

Last Price:
$2.08
Seasonality Move:
-11.41%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INDP is experiencing selling pressure, which indicates risk of future bearish movement.

Indaptus Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 2.31 Sell
20-day SMA: 2.23 Sell
50-day SMA: 2.76 Sell
200-day SMA: 8.51 Sell
8-day EMA: 2.22 Sell
20-day EMA: 2.32 Sell
50-day EMA: 2.85 Sell
200-day EMA: 10.06 Sell

Indaptus Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 38.6 Sell
Chaikin Money Flow: -27884 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.97 - 2.47) Sell
Bollinger Bands (100): (1.96 - 5.88) Sell

Indaptus Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Indaptus Therapeutics, Inc. Stock

Is Indaptus Therapeutics, Inc. Stock a Buy?

INDP Technical Analysis vs Fundamental Analysis

Sell
25
Indaptus Therapeutics, Inc. (INDP) is a Sell

Is Indaptus Therapeutics, Inc. a Buy or a Sell?

Indaptus Therapeutics, Inc. Stock Info

Market Cap:
1.2M
Price in USD:
2.03
Share Volume:
27.9K

Indaptus Therapeutics, Inc. 52-Week Range

52-Week High:
47.60
52-Week Low:
1.65
Sell
25
Indaptus Therapeutics, Inc. (INDP) is a Sell

Indaptus Therapeutics, Inc. Share Price Forecast

Is Indaptus Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Indaptus Therapeutics, Inc.

Is Indaptus Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $48.74 per share, and a decrease next year of $0.00 per share.

Technical Analysis of Indaptus Therapeutics, Inc.

Should I short Indaptus Therapeutics, Inc. stock?

* Indaptus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.